Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesTactile Systems Technology Inc

Tactile Systems Technology Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
27.22 USD 2.44 ( 9.85%)
Last update at 2026-11-04T20:59:00Z
VOLUME
678449
Market Cap
509.90M
P/E
21.04

Momentum Score

…

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
25.47
Low
28.71
High
52 Week Price Range
13.38
Low
37.77
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
24.78
Dividend Yield
-
Revenue TTM
350.31M
Revenue Per Share
15.58
Gross Profit TTM
268.97M
Debt / Equity
0.07
ROE
11.88%
Net Debt
-67.49M
ROCE
13.90%
Diluted EPS TTM
1.07

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 31.34M 23.49M 15.77M -15.47M -2.29M
Net income 19.09M 16.96M 28.52M -17.87M -11.81M
Selling general administrative 88.70M 71.14M 62.07M 60.80M 56.80M
Selling and marketing expenses 121.24M 112.01M 107.12M 106.42M 86.78M
Gross profit 247.70M 216.69M 195.13M 175.98M 148.21M
Reconciled depreciation 6.64M 6.80M 6.50M 6.27M 3.68M
Ebit 32.38M 25.57M 19.92M -4.59M -1.76M
Ebitda 39.02M 32.37M 26.42M 1.67M 1.92M
Depreciation and amortization 6.64M 6.80M 6.50M 6.27M 3.68M
Non operating income net other - - - -2.71M -0.53M
Operating income 29.28M 22.18M 18.04M -4.59M -1.76M
Other operating expenses 300.24M 270.80M 256.38M 259.54M 209.82M
Interest expense 1.04M 2.08M 4.15M 10.88M 0.53M
Tax provision 12.25M 6.53M -12.74M 2.39M 9.52M
Interest income 3.10M 3.38M 1.87M - -
Net interest income 2.06M 1.30M -2.27M - -
Income tax expense 12.25M 6.53M -12.74M 2.39M 9.52M
Total revenue 329.52M 292.98M 274.42M 246.78M 208.06M
Total operating expenses 218.42M 194.51M 177.09M 188.73M 149.97M
Cost of revenue 81.82M 76.30M 79.29M 70.81M 59.84M
Total other income expense net 2.06M 1.31M -2.27M -10.88M -0.53M
Net income from continuing ops 19.09M 16.96M 28.52M -17.87M -11.81M
Net income applicable to common shares - - - -17.87M -11.81M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 273.94M 297.92M 281.44M 255.00M 244.27M
Intangible assets 39.17M 42.79M 46.72M 50.38M 54.08M
Other current assets 23.82M 5.05M 4.37M 3.75M 4.14M
Total liab 55.04M 81.33M 87.80M 133.60M 116.04M
Total stockholder equity 218.90M 216.60M 193.64M 121.40M 128.23M
Deferred long term liab - - - - 0.03M
Other current liab 31.37M 28.05M 4.47M 48.88M 3.31M
Common stock 0.02M 0.02M 0.02M 0.02M 0.02M
Capital stock 0.02M 0.02M 0.02M 0.02M 0.02M
Retained earnings 54.94M 35.85M 18.89M -9.62M 8.24M
Other liab - - - 2.50M 6.44M
Good will 31.06M 31.06M 31.06M 31.06M 31.06M
Other assets - - - 26.10M 14.85M
Cash 83.45M 94.37M 61.03M 21.93M 28.23M
Total current liabilities 40.96M 40.70M 41.06M 64.33M 34.46M
Current deferred revenue - - 24.16M - 17.42M
Net debt -67.49M -49.26M -10.66M 50.30M 55.63M
Short term debt 3.19M 5.94M 5.76M 5.47M 8.72M
Short long term debt - 2.96M 2.96M 2.97M 6.21M
Short long term debt total 15.96M 45.11M 50.38M 72.23M 83.86M
Other stockholder equity 163.94M 180.72M 174.72M 131.00M 119.96M
Property plant equipment - - - 6.08M 6.75M
Total current assets 165.17M 177.56M 145.29M 119.76M 113.55M
Net tangible assets - - - 39.96M 43.08M
Short term investments 15.75M 14.54M 14.20M 16.13M 12.48M
Net receivables 43.88M 44.94M 43.17M 54.83M 49.48M
Long term debt - 23.22M 26.18M 45.90M 51.79M
Inventory 14.03M 18.67M 22.53M 23.12M 19.22M
Accounts payable 4.97M 5.65M 6.66M 9.98M 5.02M
Accumulated other comprehensive income - - 0.00M - -
Common stock total equity - - - 0.02M 0.02M
Retained earnings total equity - - - -9.62M 8.24M
Non currrent assets other 19.33M 5.96M 13.36M 26.40M 14.85M
Non current assets total 108.78M 120.36M 136.14M 135.23M 130.72M
Capital lease obligations 15.96M 18.93M 21.24M 23.37M 25.86M
Long term debt total - - - 45.90M 51.79M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -2.50M -2.48M -1.91M -82.18M
Change to liabilities - - - 9.92M 1.38M
Total cashflows from investing activities -2.54M -2.50M -2.48M -1.91M -82.18M
Net borrowings -26.25M -3.00M -19.75M -6.04M 54.81M
Total cash from financing activities -51.20M -4.82M 5.73M -9.60M 59.93M
Change to operating activities - - - -2.61M -3.34M
Net income 19.09M 16.96M 28.52M -17.87M -11.81M
Change in cash -10.92M 33.33M 39.10M -6.30M -19.63M
Begin period cash flow 94.37M 61.03M 21.93M 28.23M 47.85M
End period cash flow 83.45M 94.37M 61.03M 21.93M 28.23M
Total cash from operating activities 42.81M 40.66M 35.85M 5.21M 2.63M
Issuance of capital stock 0.00M 0.00M 34.62M - -
Depreciation 6.64M 6.80M 6.50M 6.27M 3.68M
Other cashflows from investing activities -0.15M -0.10M -0.16M -0.13M -80.08M
Dividends paid - - 8.26M - -
Change to inventory 4.64M 3.86M 0.60M -3.91M 0.97M
Change to account receivables -0.15M 9.17M 23.78M -15.56M -9.04M
Sale purchase of stock -26.56M -3.51M 1.54M 1.29M 2.31M
Other cashflows from financing activities -51.20M 1.68M -9.14M -4.89M 57.62M
Change to netincome - - - 21.44M 20.22M
Capital expenditures 2.38M 2.51M 2.48M 1.92M 2.35M
Change receivables - - - -5.35M -5.63M
Cash flows other operating - - - -5.30M -6.18M
Cash and cash equivalents changes - - - -6.30M -19.63M
Change in working capital 0.12M 7.71M 15.10M -4.63M -9.46M
Stock based compensation 8.36M 7.82M 7.55M 9.60M 10.17M
Other non cash items 0.08M 0.30M -2.43M 11.87M -0.18M
Free cash flow 40.43M 38.15M 33.37M 3.29M 0.28M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
TCMD
Tactile Systems Technology Inc		 2.44
9.85%		 27.22 21.04 19.12 1.46 2.28 1.26 9.94
ABT
Abbott Laboratories		 6.11
5.58%		 115.51 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 6.08
6.15%		 104.96 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 29.10
9.37%		 339.65 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -
-%		 48.37 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Tactile Systems Technology Inc

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

3701 Wayzata Boulevard, Minneapolis, MN, United States, 55416

612 355 5100

https://tactilemedical.com

1086

Name Title Year Born
Mr. Daniel L. Reuvers Pres, CEO & Director 1963
Mr. Brent A. Moen Chief Financial Officer 1967
Ms. Kristie T. Burns Sr. VP of Marketing & Clinical Affairs 1972
Mr. Eric C. Pauls Sr. VP of Sales 1975
Mr. Jerry A. Sauber VP of Operations NA
Mr. Peter C. Schaubach Chief Information Officer NA
Ms. Sunday J. Hoy VP & Compliance Officer NA
Janelle Strop Chief Human Resource Officer NA
Mr. Thomas F. O'Donnell Jr., M.D. Chief Medical Officer & Member of Vascular Strategic Advisory Board NA
Mr. Daniel L. Reuvers President, CEO & Director 1963

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…